SEHK:9969
SEHK:9969Biotechs

InnoCare Pharma (SEHK:9969) Valuation in Focus After Revenue Growth and Narrowed Losses

InnoCare Pharma (SEHK:9969) just released its latest earnings, reporting both higher revenue and a significantly smaller net loss for the nine months through September. These results are giving investors plenty to analyze right now. See our latest analysis for InnoCare Pharma. Fresh from reporting sharply reduced net losses and steadily rising revenue, InnoCare Pharma has enjoyed some serious momentum. Its share price has soared 160.98% year-to-date, and over the past year, investors have...
SEHK:1050
SEHK:1050Electronic

Asian Market Insights: 3 Penny Stocks With Market Caps Over US$20M

Amidst global concerns about AI valuations and economic uncertainties, Asian markets have mirrored some of the cautious sentiment seen in other regions. For investors interested in exploring smaller or newer companies, penny stocks continue to present intriguing opportunities despite their somewhat dated terminology. These stocks, often representing under-the-radar growth potential at lower price points, can offer significant upside when backed by strong financial health and solid fundamentals.
SEHK:981
SEHK:981Semiconductor

A Fresh Look at SMIC (SEHK:981) Valuation Following Higher Sales and Upbeat Q4 Guidance

Semiconductor Manufacturing International (SEHK:981) just released its latest earnings, showing increased sales and net income for the nine months ending September 30, 2025. The company also projected stable or slightly higher revenue for the upcoming quarter. See our latest analysis for Semiconductor Manufacturing International. On the heels of stronger sales and upbeat guidance, Semiconductor Manufacturing International’s 1-year total shareholder return stands out at 167.9%, showing...
SEHK:270
SEHK:270Water Utilities

Guangdong Investment (SEHK:270): Reviewing Valuation After Securing HKD 2.25 Billion Debt Facility

Guangdong Investment (SEHK:270) revealed acceptance of a HKD 2.25 billion committed term loan facility on 19 November 2025. The loan is aimed at funding general corporate needs and refinancing existing debt, subject to specific ownership-related covenants. See our latest analysis for Guangdong Investment. The new loan announcement comes as Guangdong Investment’s share price has steadily gained traction this year, climbing 14.8% year-to-date, with the latest move up to HK$7.59. Momentum has...